Irritable Bowel Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. comply with IBS-C, IBS-D Rome III diagnostic criteria; 2. aged 18-70 years old; 3. The duration of more than six months or more; 4. the lack of morphological changes and biochemical abnormalities could explain the symptoms; 5. baseline IBS-SSS integral >=75 points; 6. before entering the treatment, at least 2 weeks have not used any drugs for IBS (except for emergency treatment). Nearly three months without receiving acupuncture treatment for IBS, and did not participate in other ongoing clinical researches; 7. signed informed consent, voluntarily participate in the study.
Exclusion criteria
Exclusion criteria: 1. comply with IBS-M, IBS-U Rome III diagnostic criteria; 2. intestinal organic disease, or systemic diseases affect the digestive power (such as gallbladder pancreatitis, hyperthyroidism, diabetes, chronic renal failure, nervous system diseases); 3. associated with the cardiovascular system, liver, kidney, hematopoietic system, mental disorders, cognitive disorders and other serious primary disease; 4. history of abdominal or anorectal surgery; 5. often take drugs or preparations which affect gastrointestinal motility or alter intestinal function; 6. under the age of 18 or over 70 years old; 7. pregnancy, lactation, postpartum <=12 months and allergies; 8. while using other treatments or take other medications, which affect the efficacy or safety for judgments; 9. the patients into the group refuse to be observed or have other destabilizing factors, for example: Failing to comply with the provision,while taking other drugs affect the efficacy and can not judge the efficacy or having incomplete information, etc; 10. installed a pacemaker, metal allergy or severe fear of needles; 11. The involvement of other experiments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable Bowel Syndrome - severity scoring system; | — |
Secondary
| Measure | Time frame |
|---|---|
| Irritable Bowel Syndrome Quality of Life;the correlation of IBS gene subtypes and efficacy; | — |
Countries
China
Contacts
Jiangsu Provincial Traditional Chinese Medicine Hospital